Head And Neck Cancer DiagnosticsMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Head And Neck Cancer Diagnostics Market Through 2034?
The market for diagnosing head and neck cancer has seen robust expansion in the last few years. It’s set to increase from $1.74 billion in 2024 to $2.03 billion in 2025 with a compound annual growth rate (CAGR) of 16.6%. This substantial growth during the previous years is credited to factors such as tobacco and alcohol usage, a rising elderly population, increased awareness campaigns, the advancement of biopsy procedures, and the establishment of improved healthcare facilities.
In the coming years, the market size for head and neck cancer diagnostics is anticipated to experience a significant surge. By 2029, the market is projected to reach a value of $3.83 billion, reflecting a compound annual growth rate (CAGR) of 17.2%. This anticipated growth during the forecast period can be tied to various factors, including the prevalence of genomic biomarkers, the increasing cases of HPV-associated cancers, the incorporation of artificial intelligence (AI), immunotherapy and targeted therapies, as well as alterations in healthcare policies and reimbursements. Key market trends for this period are expected to encompass dominance of liquid biopsy, multi-modal diagnostics, point-of-care diagnostics, worldwide collaborations and partnerships, along with the integration of digital pathology.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12016&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Head And Neck Cancer Diagnostics Market?
The head and neck cancer diagnostics market is set to grow due to the rising cases of head and neck cancer. This cancer categorization covers tumors that attack tissues and organs in the head and neck, including the mouth, pharynx, larynx, salivary glands, nasal cavity, and sinuses. The disease is diagnosed in its early stages through various tests provided by such diagnostics, including incisional biopsy and barium swallow test. The American Society of Clinical Oncology stated in February 2023 that 4% of all cancers in the US were head and neck cancer. This cancer type is anticipated to afflict 66,920 individuals in the US in 2023, consisting of 49,190 men and 17,730 women. The disease’s global impact was evident with 562,328 confirmed cases worldwide in 2020. Specifically, Australia reported 5,189 new head and neck cancer occurrences in 2022. Therefore, due to the escalating occurrence of head and neck cancer, the head and neck cancer diagnostics market is anticipated to flourish.
Which Primary Segments of the Head And Neck Cancer Diagnostics Market Are Driving Growth and Industry Transformations?
The head and neck cancer diagnosticsmarket covered in this report is segmented –
1) By Diagnostic Method: Diagnostic Imaging Equipment, Endoscopy Screening Equipment, Biopsy Screening Tests, Dental Diagnostic Methods, Other Diagnostic Methods
2) By Channel: Retail And Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies
3) By End-User: Hospitals, Diagnostic Centers, Other End Users
Subsegments:
1) By Diagnostic Imaging Equipment: Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans, X-rays
2) By Endoscopy Screening Equipment: Rigid Endoscopes, Flexible Endoscopes, Video Endoscopy Systems
3) By Biopsy Screening Tests: Fine Needle Aspiration (FNA) Biopsy, Core Needle Biopsy, Surgical Biopsy
4) By Dental Diagnostic Methods: Intraoral Cameras, Dental X-rays, Oral Cancer Screening Devices
5) By Other Diagnostic Methods: Molecular Diagnostics, Blood Tests, Genetic Testing
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12016&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Head And Neck Cancer Diagnostics Market?# Market?
North America was the largest region in the head and neck cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Head And Neck Cancer Diagnostics Market?
The emergence of product innovation is a notable trend in the head and neck cancer diagnostic market. To solidify their market presence, leading companies are focusing on the development of novel products. As an example, in May 2023, Alkem Laboratories Ltd., a healthcare company based in India, unveiled Cetuxa, the first biosimilar globally for treating head and neck cancer. Cetuxa, a biosimilar to cetuximab, is a monoclonal antibody that interrupts the receptor-related transduction pathway and possesses anti-cancer capabilities. Cetuximab binds to the epidermal growth factor receptor (EGFR), specifically in its extracellular domain. Cetuximab is commonly used alongside chemotherapy or radiation therapy in clinical treatment. It can help to treat squamous cell carcinoma of the head and neck that is locally advanced, has recurred, or metastasized.
View the full report here:
What Parameters Are Used to Define the Head And Neck Cancer Diagnostics Market?
Head and neck cancer diagnostics refers to the process of detecting and confirming the presence of malignant cells in the head and neck region by a combination of physical examination, imaging tests, medical history evaluation, and tissue biopsy. It is commonly used to treat squamous cell carcinomas, laryngeal cancer, and hypopharyngeal cancer.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12016
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
